Cleared Traditional

K925750 - RELAXOMAT

K925750 is an FDA 510(k) clearance for RELAXOMAT, manufactured by Relaxomat, Inc.. The device is a Class 2 Neurology device with product code HCC cleared through the Traditional 510(k) pathway after a 809-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1995
Decision
809d
Days
Class 2
Risk

K925750 is an FDA 510(k) clearance for the RELAXOMAT. Classified as Device, Biofeedback (product code HCC), Class II - Special Controls.

Submitted by Relaxomat, Inc. (Tampa, US). The FDA issued a Cleared decision on January 31, 1995 after a review of 809 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5050 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

FDA 510(k) Submission Details - K925750

510(k) Number K925750 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 13, 1992
Decision Date January 31, 1995
Days to Decision 809 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
660d slower than avg
Panel avg: 149d · This submission: 809d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HCC Device Classification - Class 2, Special Controls

Product Code HCC Device, Biofeedback
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HCC Device, Biofeedback

All 172
Devices cleared under the same product code (HCC) and FDA review panel - the closest regulatory comparables to K925750.
AT64 SCR
K930577 · Autoject Systems, Inc. · May 1995
FOCUS EMG
K940050 · Fasstech · Feb 1995
NEUROSEARCH-4
K920038 · Lexicor · Feb 1995
EMG TRAINER
K935853 · Unitech · Jan 1995
PHYSIOTECH 4000 OR NORODYN 8000
K922270 · Myo-Tronics, Inc. · Sep 1994
THE MIRAGE SYSTEM BIOFEEDBACK INTERFACE
K941938 · Intercare Diagnostics, Inc. · Aug 1994